- Net Income: Orix’s net income for Q1 is 86.74 billion yen, a 38% increase year-on-year. This beats the estimated net income of 84.91 billion yen.
- Operating Income: The operating income stands at 86.27 billion yen, showing a 3.6% increase compared to last year.
- Net Sales: Orix reports net sales of 708.14 billion yen, up by 4.6% year-on-year.
- 2025 Forecast: The company maintains its net income forecast at 390.00 billion yen, slightly above the estimate of 389.4 billion yen.
- Dividends: Orix still sees a dividend of 98.60 yen, below the estimated 133.49 yen.
- Stock Ratings: The stock has 6 buy ratings, 4 hold ratings, and 0 sell ratings.
A look at Orix Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ORIX Corporation, a global provider of financial services, has received a positive outlook based on Smartkarma Smart Scores. The company scored high in key factors such as Value, Dividend, Growth, and Momentum, signaling a promising long-term outlook. Despite a slightly lower score in Resilience, ORIX Corp’s diverse business lines including leasing, real estate loans, insurance, banking, and consumer finance position it well for future growth.
With a strong focus on value, dividends, growth, and momentum, ORIX Corp’s overall outlook appears robust. The company’s extensive range of financial services combined with its unique offerings in environment-related and private equity investment businesses showcase its versatility and potential for continued success in the global market. Additionally, ORIX’s ownership of the ORIX Buffalos professional baseball team adds to its diverse portfolio and brand recognition.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
